Home

 

The meeting plans to provide a forum to discuss advances in the diagnosis and treatment of pancreatic adenocarcinoma.

loc

Confirmed speakers

June 20th


I - Basic Research

Michael Karin, University of California San Diego (USA)
Maike Sander, University of California San Diego (USA)
Marteen F. Bijlsma, University of Amsterdam (The Netherlands)
Marina Pasca di Magliano, University of Michigan (USA)
Volker Ellenrieder, University of Marburg (Germany)


II - Biomarkers
Sean Mulvihill, University of Utah (USA)
Wendy Alderton, Abcodia Ltd (UK)
VIncenzo De Laurenzi, University of Chieti-Pescara/Biounversa s.r.l. (Italy)
Matthew Firpo, University of Utah (USA)
Samir Hanash, University of Michigan (USA)
Steve Pereira, UCL Medical School (UK)
Kimberly Kelly, University of Virginia (USA)


June 21st


III - High Risk Groups
Mary P. Bronner, University of Utah (USA)
Raffaele Pezzilli,  Policlinico S.Orsola – Malpighi (Italy)
Peter Langer, University of Marburg (Germany)
Teresa A. Brentnall, University of Washington (USA)

IV - Novel therapeutics
Paul Lampe, Fred Hutchinson Research Cancer Center (USA)
Diane M. Simeone, University of Michigan (USA)
Jens Siveke, Technical University of Munich (Germany)
Craig D. Logsdon, MD Anderson Cancer Center (USA)
Fabio Francesco di Mola, University of Chieti (Italy)
Sulagna Banerjee, University of Minnesota (USA)
Giorgio Stassi,  University of Palermo (Italy)
Howard Crawford, Mayo Clinic Cancer Center (USA)
M. Caterina Turco, University of Salerno/Biouniversa s.r.l. (Italy)

 

patrocinio

 

 

 


24/07/2014